The EU-India free trade agreement is expected to double EU goods exports to India by 2032. With a specific focus on the chemicals and pharmaceuticals industries, the trade deal highlights that India will eliminate current tariffs of up to 22 % on EU chemicals and 11 % on EU pharmaceuticals while the EU will also cut tariffs to zero on Indian chemical exports as well as offer Indian pharmaceutical and medical devices companies’ preferential access to the EU market. In this scenario, what do industry leaders in the chemical and pharma space have to say about the EU-India free trade deal? Read on to find out…
Read on